• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[雌三醇膀胱内给药治疗感觉性尿急失禁的前瞻性研究]

[Intravesical administration of estriol in sensory urge incontinence--a prospective study].

作者信息

Kurz C, Nagele F, Sevelda P, Enzelsberger H

机构信息

1. Universitäts-Frauenklinik Wien.

出版信息

Geburtshilfe Frauenheilkd. 1993 Aug;53(8):535-8. doi: 10.1055/s-2007-1022929.

DOI:10.1055/s-2007-1022929
PMID:8375632
Abstract

Local intravaginal application of oestriol is part of the therapeutical programme of sensory urge-incontinence. The effectiveness of a new method--intravesical administration of 1 mg oestriol versus a placebo--has been proved in a prospective randomised study. 21 patients each were treated over a period of three weeks with oestriol or with the placebo-substance intravesically. The effectiveness of the administered therapy was checked with clinical and urodynamic parameters. The intravesical administration of 1 mg oestriol proved to be efficient and free of side effects in respect of the parameters such as imperative micturition, bladder capacity, of the maximum urethral closure pressure as well as the number of micturitions per diem. The intravesical administration of oestriol may be considered as additional method of therapy for treatment of sensory urge-incontinence.

摘要

局部阴道内应用雌三醇是感觉性尿急失禁治疗方案的一部分。一项前瞻性随机研究证实了一种新方法——膀胱内给予1毫克雌三醇与安慰剂相比——的有效性。每组21例患者接受为期三周的膀胱内雌三醇或安慰剂治疗。通过临床和尿动力学参数检查所给予治疗的有效性。就迫切性排尿、膀胱容量、最大尿道闭合压以及每日排尿次数等参数而言,膀胱内给予1毫克雌三醇被证明是有效的且无副作用。膀胱内给予雌三醇可被视为治疗感觉性尿急失禁的一种额外治疗方法。

相似文献

1
[Intravesical administration of estriol in sensory urge incontinence--a prospective study].[雌三醇膀胱内给药治疗感觉性尿急失禁的前瞻性研究]
Geburtshilfe Frauenheilkd. 1993 Aug;53(8):535-8. doi: 10.1055/s-2007-1022929.
2
[The effectiveness of intravaginal estriol tablet administration in women with urge incontinence].[阴道内给予雌三醇片治疗急迫性尿失禁女性的疗效]
Geburtshilfe Frauenheilkd. 1991 Oct;51(10):834-8. doi: 10.1055/s-2008-1026219.
3
[Comparison of emepronium bromide with intravesical administration of lidocaine gel in women with urge incontinence].[溴美喷酯与膀胱内灌注利多卡因凝胶治疗女性急迫性尿失禁的比较]
Geburtshilfe Frauenheilkd. 1991 Jan;51(1):54-7. doi: 10.1055/s-2008-1026333.
4
[Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].[盐酸奥昔布宁局部给药治疗女性急迫性尿失禁。一项前瞻性随机双盲研究的结果]
Geburtshilfe Frauenheilkd. 1995 May;55(5):240-3. doi: 10.1055/s-2007-1023310.
5
[Intravesical administration of estriol as a possible form of therapy of sensory urge incontinence].[雌三醇膀胱内给药作为感觉性尿急失禁的一种可能治疗方式]
Gynakol Rundsch. 1991;31 Suppl 2:326-7.
6
[Effectiveness of intravesical administration of lidocaine gel in females with urge and urge incontinence].[利多卡因凝胶膀胱内给药对女性急迫性和急迫性尿失禁的疗效]
Geburtshilfe Frauenheilkd. 1988 Aug;48(8):562-6. doi: 10.1055/s-2008-1026539.
7
[Vaginal estriol administration in treatment of postmenopausal urinary incontinence].阴道用雌三醇治疗绝经后尿失禁
Urologe A. 1992 Nov;31(6):384-9.
8
Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.膀胱内注射树脂毒素对脊髓源性神经源性逼尿肌过度活动患者的尿动力学影响:一项双盲随机安慰剂对照试验的结果
Eur Urol. 2005 Oct;48(4):650-5. doi: 10.1016/j.eururo.2005.04.012.
9
[Comparative study of the effectiveness of an intravesical administered lidocaine gel versus emepronium bromide in females with urge incontinence].膀胱内注射利多卡因凝胶与溴美喷酯治疗女性急迫性尿失禁有效性的比较研究
Gynakol Rundsch. 1989;29 Suppl 2:346-8.
10
[Treatment of female urge incontinence by local estrogen therapy].[局部雌激素疗法治疗女性急迫性尿失禁]
Gynakol Rundsch. 1990;30 Suppl 1:235-6.

引用本文的文献

1
Oestrogen therapy for urinary incontinence in post-menopausal women.绝经后女性尿失禁的雌激素治疗
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD001405. doi: 10.1002/14651858.CD001405.pub3.